Annual and Special Reporting by the Firm
Auditor Reporting of Certain Audit Participants
Form | Filed Date | Issuer Name | Audit Report Date | Engagement Partner | |
Form AP
|
04/17/2024
|
Lava Therapeutics N.V.
|
03/20/2024
|
Hormann-Buiting, Marieke
|
|
Form AP/A
|
03/15/2024
|
VEON Ltd.
|
07/24/2023
|
de Ridder, Michael
|
|
Form AP
|
08/16/2023
|
VEON Ltd.
|
07/24/2023
|
de Ridder, Michael
|
|
Form AP
|
05/08/2023
|
Pharvaris N.V.
|
04/05/2023
|
Voorthuijsen, Willem
|
|
Form AP
|
05/08/2023
|
LAVA Therapeutics NV
|
04/11/2023
|
Middelweerd, Johannes Wilhelmus
|
|
Form AP
|
04/20/2023
|
Aegon N.V.
|
03/22/2023
|
van Adrichem, Rogier
|
|
Form AP
|
06/03/2022
|
VEON Ltd.
|
04/29/2022
|
van der Molen, Wytse
|
|
Form AP
|
04/27/2022
|
LAVA Therapeutics NV
|
03/24/2022
|
Admiraal, Ron
|
|
Form AP
|
04/27/2022
|
Pharvaris N.V
|
03/29/2022
|
Admiraal, Ron
|
|
Form AP
|
04/15/2022
|
Aegon N.V.
|
03/21/2022
|
Heuvelink, Gert-Jan
|
|
Form AP/A
|
01/18/2022
|
VEON Ltd.
|
03/15/2021
|
van der Molen, Wytse
|
|
Form AP
|
04/16/2021
|
VEON Ltd.
|
03/15/2021
|
van der Molen, Wytse
|
|
Form AP
|
08/13/2021
|
Pharming Group N.V.
|
10/14/2020
|
Admiraal, Ron
|
|
Form AP
|
05/27/2021
|
Pharvaris N.V.
|
04/29/2021
|
Admiraal, Ron
|
|
Form AP
|
04/20/2021
|
Aegon N.V.
|
03/17/2021
|
Heuvelink, Gert-Jan
|
|
Form AP
|
03/26/2021
|
LAVA Therapeutics BV
|
03/02/2021
|
Admiraal, Ron
|
|
Form AP
|
03/17/2021
|
Pharvaris N.V.
|
11/10/2020
|
Admiraal, Ron
|
|
Form AP
|
03/11/2021
|
LAVA Therapeutics BV
|
03/02/2021
|
Admiraal, Ron
|
|
Form AP
|
04/16/2020
|
Aegon N.V.
|
03/18/2020
|
Heuvelink, Gert-Jan
|
|
Form AP
|
04/15/2020
|
VEON Ltd.
|
03/13/2020
|
van der Molen, Wytse
|
|
Form AP
|
04/12/2019
|
VEON Ltd.
|
03/14/2019
|
Izeboud, Fernand
|
|
Form AP
|
04/12/2019
|
Aegon N.V.
|
03/21/2019
|
Heuvelink, Gert-Jan
|
|
|
Currently Subject to Board Determination Under the Holding Foreign Companies Accountable Act?
|